(19)
(11) EP 1 385 841 A1

(12)

(43) Date of publication:
04.02.2004 Bulletin 2004/06

(21) Application number: 02725952.2

(22) Date of filing: 07.05.2002
(51) International Patent Classification (IPC)7C07D 403/10, C07D 419/10, A61K 31/41, A61K 31/433, A61P 9/00
(86) International application number:
PCT/US2002/014408
(87) International publication number:
WO 2002/090353 (14.11.2002 Gazette 2002/46)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 07.05.2001 US 289306 P

(71) Applicant: SmithKline Beecham Corporation
Philadelphia, PA 19103 (US)

(72) Inventors:
  • DHANAK, Dashyant
    King of Prussia, PA 19406 (US)
  • GALLAGHER, Timothy, F.
    Collegeville, PA 19426 (US)
  • KNIGHT, Steven, D.
    King of Prussia, PA 19406 (US)

(74) Representative: Hockley, Siân Catherine 
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) SULFONAMIDES